Compression Therapy Market to Reach USD 5.76 Billion by 2031
The global compression therapy market is projected to grow from USD 4.52 billion in 2026 to USD 5.76 billion by 2031, at a compound annual growth rate of 4.96%. The expansion is driven by rising venous disorders and advanced technologies.
The global market for compression therapy is forecast to reach USD 5.76 billion by 2031, an increase from an estimated USD 4.52 billion in 2026. The market is expected to grow at a compound annual growth rate of 4.96% during the forecast period.
The growth is primarily fueled by the increasing prevalence of venous disorders, such as chronic venous insufficiency and venous leg ulcers, as well as lymphedema. An aging global population and greater awareness of the benefits of compression therapy are also contributing to market expansion.
Technological advancements are playing a key role, with manufacturers developing smart textiles and dynamic compression systems offering adjustable pressure. Innovations in fabric comfort, moisture management, and remote monitoring are aimed at improving patient adherence. The use of compression products in sports recovery and preventive wellness is also broadening the market beyond traditional clinical applications.
North America currently holds the largest share of the market, supported by its developed healthcare infrastructure and reimbursement policies. The Asia-Pacific region is identified as the fastest-growing market, driven by demographic shifts and improving healthcare services. Europe maintains a significant position, with demand for medical compression garments and products for managing chronic wounds and venous diseases.